Venkatesan Jay — SEC insider filings

SEC reporting owner CIK 1413350. 28 insider filings on record with FilingPulse; latest filed 2026-09-02.

Transaction summary — filings shown

Covers all 28 filings on record, filed 2020-12-22 to 2026-09-02. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Elicio Therapeutics, Inc. (ELTX)Director179 legs · 493,513 sh · $1,147,7872 legs · 318,354 sh · $5,093,66430
ALPINE IMMUNE SCIENCES, INC. (ALPN)Director, 10% owner6—1 leg · 400,000 sh · $3,760,00010
Serina Therapeutics, Inc. (SER)Director51 leg · 589 sh · $1,048—7

Insider filings — Venkatesan Jay

FiledFormIssuerReported transactionsSource
2026-09-024Elicio Therapeutics, Inc. (ELTX)Grant/award (A): 21,750 (derivative) @ $0EDGAR
2026-06-224Serina Therapeutics, Inc. (SER)Purchase (P): 589 @ $1.78 · Conversion (C): 224,152 @ $2.25 · Grant/award (A): 15,250 (derivative) @ $0 · Conversion (C): 96,525 (derivative) @ $2.25EDGAR
2026-04-214Serina Therapeutics, Inc. (SER)Grant/award (A): 7,553 @ $1.94EDGAR
2025-11-104Serina Therapeutics, Inc. (SER)Grant/award (A): 10,000 (derivative) @ $0EDGAR
2025-05-204Elicio Therapeutics, Inc. (ELTX)Grant/award (A): 7,900 (derivative) @ $0EDGAR
2025-04-104Serina Therapeutics, Inc. (SER)Grant/award (A): 96,525 (derivative) @ $5.18EDGAR
2025-02-134Serina Therapeutics, Inc. (SER)Grant/award (A): 40,000 (derivative) @ $0EDGAR
2025-01-024/AElicio Therapeutics, Inc. (ELTX)Purchase (P): 50,000 (derivative) @ $0 · Purchase (P): 50,000 (derivative) @ $4.99EDGAR
2024-11-294Elicio Therapeutics, Inc. (ELTX)Option exercise/expiry (X): 50,000 @ $0.01 · Option exercise/expiry (X): 50,000 (derivative) @ $0EDGAR
2024-11-254Elicio Therapeutics, Inc. (ELTX)Grant/award (A): 4,100 (derivative) @ $0EDGAR
2024-07-024Elicio Therapeutics, Inc. (ELTX)Purchase (P): 50,000 (derivative) @ $0 · Purchase (P): 50,000 (derivative) @ $4.99 · Purchase (P): 50,000 (derivative) @ $0 · Purchase (P): 50,000 (derivative) @ $4.99 · Purchase (P): 50,000 (derivative) @ $0 · Purchase (P): 50,000 (derivative) @ $4.99 · +2 moreEDGAR
2023-12-294Elicio Therapeutics, Inc. (ELTX)Grant/award (A): 4,100 (derivative) @ $0EDGAR
2022-07-194ALPINE IMMUNE SCIENCES, INC. (ALPN)Option exercise (M): 20,063 @ $0.45 · Option exercise (M): 20,063 (derivative) @ $0.45EDGAR
2022-05-274/AAngion Biomedica Corp. (ANGN)Option exercise/expiry (X): 396,329 @ $6.43 · Sale (S): 159,177 @ $16 · Conversion (C): 262 @ $11.57 · Option exercise/expiry (X): 396,329 (derivative) @ $0EDGAR
2022-05-274Angion Biomedica Corp. (ANGN)Purchase (P): 11,313 @ $1.25EDGAR
2022-05-254Angion Biomedica Corp. (ANGN)Purchase (P): 50,000 @ $1.23 · Purchase (P): 32,200 @ $1.24EDGAR
2022-03-044Angion Biomedica Corp. (ANGN)Grant/award (A): 600,000 (derivative) @ $0 · Grant/award (A): 160,000 (derivative) @ $0EDGAR
2022-01-044ALPINE IMMUNE SCIENCES, INC. (ALPN)Grant/award (A): 10,000 (derivative) @ $0EDGAR
2021-12-294Angion Biomedica Corp. (ANGN)Purchase (P): 66,907 @ $2.55 · Purchase (P): 210,337 @ $2.66EDGAR
2021-12-224Angion Biomedica Corp. (ANGN)Purchase (P): 3,527 @ $2.54EDGAR
2021-12-204Angion Biomedica Corp. (ANGN)Purchase (P): 27,883 @ $2.55 · Purchase (P): 13,742 @ $2.54EDGAR
2021-12-174Angion Biomedica Corp. (ANGN)Tax withholding (F): 41,091 @ $13.78 · Purchase (P): 77,604 @ $2.41EDGAR
2021-09-214ALPINE IMMUNE SCIENCES, INC. (ALPN)Sale (S): 400,000 @ $9.40EDGAR
2021-04-234ALPINE IMMUNE SCIENCES, INC. (ALPN)Option exercise (M): 7,650 @ $4.09 · Option exercise (M): 7,650 @ $3.62 · Option exercise (M): 7,650 (derivative) @ $0 · Option exercise (M): 7,650 (derivative) @ $0EDGAR
2021-02-114Angion Biomedica Corp. (ANGN)Tax withholding (F): 31,966 @ $16 · Conversion (C): 165,094 · Option exercise/expiry (X): 237,152 @ $6.43 · Sale (S): 159,177 @ $16 · Conversion (C): 262 @ $11.57 · Conversion (C): 1,804 (derivative) @ $0 · +2 moreEDGAR
2021-02-084Angion Biomedica Corp. (ANGN)Grant/award (A): 178,920 (derivative) @ $0EDGAR
2021-01-054ALPINE IMMUNE SCIENCES, INC. (ALPN)Grant/award (A): 7,650 (derivative) @ $0EDGAR
2020-12-224ALPINE IMMUNE SCIENCES, INC. (ALPN)Other (J): 993,801 @ $0 · Other (J): 181,024 @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2020-12-17 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1413350 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs